2023•Hypertension JournalOpen access

High Intensity Statins in Acute Coronary Syndrome Part II: A comparison of Atorvastatin and Rosuvastatin for use in ACS, Clinical trials in India and Place for statins in current guidelines

Pranay Gupta, Utsav Anand Mani, Mukesh Kumar, Haider Abdul Raheem Abbas

Abstract

The role of high-intensity statins in the management of Acute Coronary Syndrome (ACS) has been a focal point of cardiovascular research, with a particular emphasis on comparing the efficacy and safety of Atorvastatin (ATV) and Rosuvastatin (RSV) in mitigating cardiovascular risk.

Open-access reader

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Rosuvastatin, Atorvastatin, Acute coronary syndrome, Medicine, Internal medicine, Statin, Cardiology, Clinical trial